Cargando…
Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents
Kidney injury caused by anticancer agents is a common problem that can interfere with and affect the dose intensity of anticancer therapy, thus restricting patient survival. Recent advances in targeted and immunotherapeutic agents have transformed the landscape of medical oncology, and these agents...
Autor principal: | Hong, Min Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Nephrology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476309/ https://www.ncbi.nlm.nih.gov/pubmed/34233435 http://dx.doi.org/10.23876/j.krcp.21.037 |
Ejemplares similares
-
Nephrotoxicity of recent anti-cancer agents
por: Lameire, Norbert
Publicado: (2014) -
Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review
por: Heidari-Soreshjani, Saeid, et al.
Publicado: (2017) -
Plant-Derived Agents for Counteracting Cisplatin-Induced Nephrotoxicity
por: Ojha, Shreesh, et al.
Publicado: (2016) -
The 6R’s of drug induced nephrotoxicity
por: Awdishu, Linda, et al.
Publicado: (2017) -
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations
por: Piscitani, Luca, et al.
Publicado: (2020)